Natera, Inc. (NASDAQ: NTRA) will report its first quarter 2024 results on May 9. The company is a global leader in cell-free DNA and genetic testing. The earnings conference call will take place at 1:30 p.m. PT (4:30 p.m. ET) on the same day.
Natera, Inc. (NASDAQ: NTRA) pubblicherà i risultati del primo trimestre del 2024 il 9 maggio. L'azienda è leader globale nei test del DNA libero circolante e genetici. La teleconferenza sugli utili si terrà alle 13:30 PT (16:30 ET) dello stesso giorno.
Natera, Inc. (NASDAQ: NTRA) presentará los resultados del primer trimestre de 2024 el 9 de mayo. La empresa es líder mundial en pruebas de ADN libre de células y genéticas. La conferencia sobre los resultados tendrá lugar a la 1:30 p.m. PT (4:30 p.m. ET) el mismo día.
나테라(Natera, Inc., 나스닥: NTRA)는 2024년 1분기 실적을 5월 9일에 발표합니다. 이 회사는 무세포 DNA 및 유전자 검사의 세계적인 리더입니다. 실적 발표 전화 회의는 같은 날 오후 1시 30분 PT(오후 4시 30분 ET)에 진행됩니다.
Natera, Inc. (NASDAQ : NTRA) annoncera les résultats du premier trimestre 2024 le 9 mai. L'entreprise est un leader mondial dans les tests d'ADN sans cellule et génétiques. La conférence téléphonique sur les résultats aura lieu à 13h30 PT (16h30 HE) le même jour.
Natera, Inc. (NASDAQ: NTRA) wird die Ergebnisse für das erste Quartal 2024 am 9. Mai veröffentlichen. Das Unternehmen ist ein weltweiter Marktführer in der zellfreien DNA- und genetischen Testung. Die Telefonkonferenz zu den Ergebnissen findet am selben Tag um 13:30 Uhr PT (16:30 Uhr ET) statt.
Positive
None.
Negative
None.
AUSTIN, Texas--(BUSINESS WIRE)--
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its first quarter ended March 31, 2024, after the market close on May 9, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).
Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
